Source link : https://www.newshealth.biz/health-news/chemoradiation-best-in-hpv-associated-oropharyngeal-cancer/
WASHINGTON — Reduced doses of radiation therapy and immunotherapy did not work as well as the standard chemoradiation for early-stage HPV-associated oropharyngeal cancer, in a new study. These findings, which caused the study to be suspended, underscore the efficacy of the current standard-of-care treatment and highlight the challenges in de-intensifying therapy for this patient population, […]
Author : News Health
Publish date : 2024-10-04 06:47:51
Copyright for syndicated content belongs to the linked Source.